Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: A potential mechanism for increasing IGF bioavailability

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 3, 2010, Pages 1412-1420

  Yan, Xiaolang ^a   Baxter, Robert C ^a   Firth, Sue M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C RECEPTOR;

ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; FEMALE; HUMAN; NORMAL HUMAN; PLASMA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

EID: 77749270588     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2277     Document Type: Article

References (34)

1. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
2. Firth SM, McDougall F, McLachlan AJ, Baxter RC 2002 Impaired blockade of insulin-like growth factor I (IGF-I)-induced hypoglycemia by IGF binding protein-3 analog with reduced ternary complex-forming ability. Endocrinology 143:1669-1676
3. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M 1990 Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the '150-K' complex during pregnancy. J Clin Endocrinol Metab 71:797-805
4. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 71: 806-816
5. Claussen M, Zapf J, Braulke T 1994 Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid. Endocrinology 134:1964-1966
6. Davies SC, Wass JA, Ross RJ, Cotterill AM, Buchanan CR, Coulson VJ, Holly JM 1991 The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 130:469-473
7. Davenport ML, Isley WL, Pucilowska JB, Pemberton LB, Lyman B, Underwood LE, Clemmons DR 1992 Insulin-like growth factor binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab 75:590-595
8. Yan X, Payet LD, Baxter RC, Firth SM 2009 Activity of Human Pregnancy Insulin-Like Growth Factor Binding Protein-3: Determination by Reconstituting Recombinant Complexes. Endocrinology 150:4968-4976
9. Suikkari AM, Baxter RC 1992 Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum. J Clin Endocrinol Metab 74:177-183
10. Liu F, Baxter RC, Hintz RL 1992 Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum. J Clin Endocrinol Metab 75:1261-1267
11. Baxter RC, Meka S, Firth SM 2002 Molecular distribution of IGF binding protein-5 in human serum. J Clin Endocrinol Metab 87: 271-276
12. Laursen LS, Overgaard MT, Soe R, Boldt HB, Sottrup-Jensen L, Giudice LC, Conover CA, Oxvig C 2001 Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 504:36-40
13. Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, Oxvig C 2001 Pregnancy-associated plasma protein-A2 (PAPPA2), a novel insulin-like growth factor-binding protein-5 proteinase. J Biol Chem 276:21849-21853
14. Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer UM 2000 ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 278:511-515
15. Kubler B, Cowell S, Zapf J, Braulke T 1998 Proteolysis of insulinlike growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum. Endocrinology 139:1556-1563
16. Zapf J, Hauri C, Futo E, Hussain M, Rutishauser J, Maack CA, Froesch ER 1995 Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. J Clin Invest 95:179-186
17. Bar RS, Boes M, Dake BL, Sandra A, Bayne M, Cascieri M, Booth BA1990 Tissue localization of perfused endothelial cell IGF binding protein is markedly altered by association with IGF-I. Endocrinology 127:3243-3245
18. Galvani M, Bordini E, Piubelli C, Hamdan M 2000 Effect of experimental conditions on the analysis of sodium dodecyl sulphate polyacrylamide gel electrophoresis separated proteins by matrix-assisted laser desorption/ ionisation mass spectrometry. RapidCommun Mass Spectrom 14:18-25
19. Kaleko M, Rutter WJ, Miller AD 1990 Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10:464-473
20. Ständker L, Wobst P, Mark S, Forssmann WG 1998 Isolation and characterization of circulating 13-kDa C-terminal fragments of human insulin-like growth factor binding protein-5. FEBS Lett 441: 281-286
21. Bischof P 1989 Three pregnancy proteins (PP12, PP14, and PAPPA): their biological and clinical relevance.AmJ Perinatol 6:110-116
22. Zheng B, Clarke JB, Busby WH, Duan C, Clemmons DR 1998 Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin. Endocrinology 139:1708-1714
23. Laursen LS, Overgaard MT, Nielsen CG, Boldt HB, Hopmann KH, Conover CA, Sottrup-Jensen L, Giudice LC, Oxvig C 2002 Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. Biochem J 367:31-40
24. Graham ME, Kilby DM, Firth SM, Robinson PJ, Baxter RC 2007 The in vivo phosphorylation and glycosylation of human insulin-like growth factor-binding protein-5. Mol Cell Proteomics 6:1392-1405
25. Schebek-Fürstenberg V, Ständker L, Oppermann M, Müller-Wiefel DE, Hahn W, Blum WF, Braulke T, Kübler B 2004 IGF-binding protein-3 fragments in plasma of a child with acute renal failure. Pediatr Nephrol 19:1418-1425
26. Farr M, Strübe J, Geppert HG, Kocourek A, Mahne M, Tschesche H 2000 Pregnancy-associated plasma protein-E (PAPP-E). Biochim Biophys Acta 1493:356-362
27. Wang J, Qiu Q, Haider M, Bell M, Gruslin A, Christians JK 2009 Expression of pregnancy associated plasma protein A2 (PAPPA2) during pregnancy in human and mouse. J Endocrinol 202:337-345
28. Nishizawa H, Pryor-Koishi K, Suzuki M, Kato T, Kogo H, Sekiya T, Kurahashi H, Udagawa Y 2008 Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. Mol Hum Reprod 14:595-602
29. Bischof P, Reyes H, Herrmann WL, Sizonenko PC 1983 Circulating levels of pregnancy-associated plasma protein-A (PAPP-A) and human chorionic gonadotrophin (hCG) in intrauterine and extrauterine pregnancies. Br J Obstet Gynaecol 90:323-325
30. Bischof P, DuBerg S, Herrmann W, Sizonenko PC 1981 Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy. Br J Obstet Gynaecol 88:973-975
31. Byun D, Mohan S, Yoo M, Sexton C, Baylink DJ, Qin X 2001 Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J Clin Endocrinol Metab 86:847-854
32. Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, Gleich GJ, Sottrup-Jensen L, Conover CA, Oxvig C 2000 Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275:31128-31133
33. Laursen LS, Kjaer-Sorensen K, Andersen MH, Oxvig C 2007 Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5. Mol Endocrinol 21:1246-1257
34. Tripathi G, Salih DA, Drozd AC, Cosgrove RA, Cobb LJ, Pell JM 2009 IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo. FASEB J 23:2616-2626